Presented by Sherita Meyer-Gausen, MD Anderson Cancer Center
PD-L1 is a protein that allows some cells to escape an attack by the immune system. Analyzing tumor cells for PD-L1 by IHC helps determine if patients will benefit from immune checkpoint inhibitors (cancer drugs). This webinar will discuss this protein and will include IHC technique, clinical features, and challenges and issues.